BED / EQD2

ورودی‌های بالینی بیمار

حداقل ۱ — حداکثر ۱۲۰ • واحد: Gy

حداقل ۱ — حداکثر ۶۰

حداقل ۰.۵ — حداکثر ۳۰ • واحد: Gy

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
bed
—Gy
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Result≥ 0
Direct Clinical Answer

The BED / EQD2 calculates staging malignant disease, estimating overall survival, and assessing chemotherapy tolerability. Key inputs include total dose gy. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Biologically effective dose and equivalent dose in 2-Gy fractions.

Clinical Indication

The BED / EQD2 is indicated for bedside clinical practice to support Biologically effective dose and equivalent dose in 2-Gy fractions.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.

Limitations & Contraindications

Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.

Clinical Pearls & Action Plan

Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival.

Formula & Variables:

BED = n x d x (1 + d/(a/b)); EQD2 = D x (d + a/b)/(2 + a/b). Report returns BED.

Input Parameters

NameTypeRequiredDescription
total_dose_gyfloatYesTotal dose (1-120 Gy)(Gy)
fractionsfloatYesNumber of fractions (1-60)
alpha_betafloatYesAlpha/beta ratio (0.5-30 Gy)(Gy)

Score Interpretation & Guidance

RangeStageDescription
≥ 0ResultBED

Evidence-Based References (EBM)

  • Fowler JF. The linear-quadratic formula and progress in fractionation. Br J Radiol. 1989;62(734):679-694.

Related calculators